Insider · CIK 0001721020
Alpna Seth
director
Files at TECH (BIO-TECHNE Corp), KROS (Keros Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 30, 2025 | TECH BIO-TECHNE Corp | AGrant or award Common Stock | +1,640 | $0.00 | $0 | 15,411 | Nov 3, 2025 |
| Oct 30, 2025 | TECH BIO-TECHNE Corp | AGrant or award Stock Options (Right to Buy)derivative | +3,777 | $0.00 | $0 | 3,777 | Nov 3, 2025 |
| Jun 4, 2025 | KROS Keros Therapeutics, Inc. | AGrant or award Common Stock | +5,250 | $0.00 | $0 | 5,250 | Jun 6, 2025 |
| Jun 4, 2025 | KROS Keros Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +10,500 | $0.00 | $0 | 10,500 | Jun 6, 2025 |
| Oct 24, 2024 | TECH BIO-TECHNE Corp | AGrant or award Common Stock | +1,462 | $0.00 | $0 | 13,771 | Oct 28, 2024 |
| Oct 24, 2024 | TECH BIO-TECHNE Corp | AGrant or award Stock Options (Right to Buy)derivative | +3,511 | $0.00 | $0 | 3,511 | Oct 28, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.